Profile data is unavailable for this security.
About the company
Stryker Corporation (Stryker) is a medical technology company. The Company offers products and services in Medical and Surgical, Neurotechnology, Orthopedics and Spine that help improve patient and healthcare outcomes. The Company operates through two segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. Its products are sold in over 75 countries through Company-owned subsidiaries and branches, as well as through third-party dealers and distributors. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties. Its geographical segments include United States and International.
- Revenue in USD (TTM)18.45bn
- Net income in USD2.36bn
- Incorporated1946
- Employees51.00k
- LocationStryker Corp2825 Airview BlvdKALAMAZOO 49002United StatesUSA
- Phone+1 (269) 389-2600
- Fax+1 (269) 385-1062
- Websitehttps://www.stryker.com/
More ▼
Mergers & acquisitions
| Acquired company | SYK:NYQ since announced | Transaction value |
|---|---|---|
| Cerus Endovascular Inc | 35.43% | -- |
Data delayed at least 15 minutes, as of Mar 29 2023 21:10 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Insulet Corporation | 1.31bn | 4.60m | 21.76bn | 2.60k | 5,608.53 | 45.66 | 320.94 | 16.67 | 0.0558 | 0.0558 | 18.63 | 6.85 | 0.6071 | 1.54 | 7.12 | 502,038.50 | 0.214 | 0.5725 | 0.2482 | 0.6537 | 61.72 | 64.86 | 0.3524 | 0.9346 | 2.65 | 2.38 | 0.7464 | 0.00 | 18.79 | 22.99 | -72.62 | -- | 15.29 | -- |
| Align Technology, Inc. | 3.73bn | 361.57m | 23.46bn | 23.17k | 66.59 | 6.57 | 48.13 | 6.28 | 4.60 | 4.60 | 47.62 | 46.61 | 0.6282 | 3.87 | 4.25 | 161,218.90 | 6.08 | 19.64 | 8.99 | 28.85 | 70.52 | 72.42 | 9.68 | 25.93 | 1.08 | -- | 0.00 | 0.00 | -5.51 | 20.44 | -53.17 | 2.75 | 8.33 | -- |
| West Pharmaceutical Services Inc. | 2.89bn | 580.20m | 25.10bn | 10.70k | 44.15 | 9.33 | 36.91 | 8.70 | 7.66 | 7.73 | 38.11 | 36.23 | 0.8331 | 4.41 | 5.79 | 269,803.80 | 16.15 | 14.87 | 19.24 | 17.73 | 39.36 | 37.06 | 19.38 | 17.14 | 2.90 | -- | 0.0722 | 12.01 | 1.95 | 12.54 | -12.14 | 20.06 | 16.82 | 6.61 |
| Zimmer Biomet Holdings Inc | 6.94bn | 290.20m | 26.62bn | 18.00k | 91.90 | 2.20 | 21.87 | 3.84 | 1.38 | 1.10 | 33.02 | 57.51 | 0.3118 | 0.8893 | 4.98 | 385,550.00 | 1.31 | 0.976 | 1.51 | 1.11 | 70.90 | 71.16 | 4.20 | 3.28 | 0.9669 | 7.44 | 0.3214 | 84.88 | 1.65 | -2.32 | -34.79 | -11.73 | -1.98 | 0.00 |
| Resmed Inc | 3.76bn | 809.47m | 31.37bn | 8.16k | 38.82 | 8.36 | 32.57 | 8.34 | 5.50 | 5.50 | 25.58 | 25.53 | 0.6596 | 2.06 | 6.04 | 461,185.70 | 14.19 | 13.19 | 16.10 | 15.51 | 56.71 | 57.33 | 21.51 | 18.67 | 1.82 | 22.56 | 0.3251 | 40.45 | 11.93 | 11.60 | 64.26 | 17.89 | 16.90 | 4.94 |
| GE HealthCare Technologies Inc | 18.34bn | 1.90bn | 35.97bn | 50.00k | 18.95 | 3.85 | 13.93 | 1.96 | 4.18 | 4.22 | 40.43 | 20.58 | -- | -- | -- | 366,820.00 | -- | -- | -- | -- | 39.14 | -- | 10.63 | -- | 0.857 | 32.48 | 0.4624 | -- | 4.30 | -- | -14.85 | -- | -- | -- |
| DexCom, Inc. | 2.91bn | 341.20m | 44.04bn | 7.50k | 142.30 | 20.65 | 88.59 | 15.13 | 0.8009 | 0.8009 | 6.84 | 5.52 | 0.5636 | 3.05 | 4.74 | 387,973.30 | 6.61 | 6.48 | 8.79 | 7.85 | 65.19 | 66.58 | 11.73 | 11.04 | 1.83 | 1,012.75 | 0.4878 | 0.00 | 18.84 | 32.28 | 57.31 | 43.79 | 40.77 | -- |
| Edwards Lifesciences Corp | 5.38bn | 1.52bn | 49.48bn | 17.30k | 33.48 | 8.55 | 29.78 | 9.19 | 2.44 | 2.44 | 8.62 | 9.55 | 0.641 | 1.35 | 8.79 | 311,121.40 | 18.12 | 16.32 | 20.65 | 19.04 | 79.96 | 76.32 | 28.28 | 24.43 | 2.17 | -- | 0.0931 | 0.00 | 2.86 | 9.40 | 1.25 | 11.64 | 8.57 | -- |
| Becton Dickinson and Co | 18.74bn | 1.49bn | 68.84bn | 77.00k | 46.93 | 2.71 | 18.43 | 3.67 | 5.18 | 5.30 | 65.34 | 89.72 | 0.3519 | 3.12 | 8.40 | 243,350.70 | 2.96 | 2.21 | 3.42 | 2.51 | 44.78 | 45.78 | 8.41 | 6.55 | 0.5995 | 6.32 | 0.3925 | 86.56 | -1.36 | 9.31 | 2.05 | 8.45 | 6.00 | -- |
| Boston Scientific Corporation | 12.68bn | 642.00m | 70.54bn | 45.00k | 110.04 | 4.00 | 39.61 | 5.56 | 0.446 | 0.446 | 8.81 | 12.26 | 0.392 | 2.26 | 6.77 | 281,822.20 | 2.16 | 2.75 | 2.47 | 3.28 | 69.00 | 69.03 | 5.52 | 7.01 | 1.02 | 8.20 | 0.3371 | 0.00 | 6.68 | 6.99 | -34.82 | -7.83 | 5.50 | -- |
| Intuitive Surgical, Inc. | 6.22bn | 1.32bn | 87.83bn | 12.12k | 68.67 | 7.95 | 50.57 | 14.12 | 3.65 | 3.65 | 17.19 | 31.55 | 0.4691 | 2.74 | 7.21 | 513,382.80 | 10.14 | 12.86 | 11.28 | 14.29 | 67.44 | 68.30 | 21.61 | 27.14 | 3.77 | -- | 0.00 | 0.00 | 8.97 | 14.67 | -22.43 | 5.99 | 22.79 | -- |
| Medtronic PLC | 30.77bn | 4.06bn | 105.20bn | 95.00k | 25.99 | 2.04 | 15.48 | 3.42 | 3.04 | 3.04 | 23.06 | 38.67 | 0.331 | 2.07 | 5.43 | 323,915.80 | 4.40 | 5.08 | 5.04 | 5.72 | 66.72 | 68.46 | 13.29 | 15.45 | 1.39 | 23.05 | 0.3527 | 62.61 | 5.21 | 1.30 | 43.97 | 4.58 | 1.76 | 7.94 |
| Stryker Corp | 18.45bn | 2.36bn | 105.79bn | 51.00k | 45.22 | 6.36 | 31.52 | 5.73 | 6.17 | 6.17 | 48.27 | 43.88 | 0.516 | 1.86 | 5.60 | 361,745.10 | 6.59 | 6.43 | 7.77 | 7.59 | 63.14 | 64.87 | 12.78 | 12.79 | 0.9964 | -- | 0.4399 | 44.45 | 7.84 | 8.19 | 18.25 | 4.94 | -0.3367 | 10.77 |
Data as of Mar 29 2023. Currency figures normalised to Stryker Corp's reporting currency: US Dollar USD
37.81%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2022 | 28.83m | 7.61% |
| Greenleaf Asset Management, Inc.as of 21 Mar 2023 | 21.05m | 5.56% |
| Wellington Management Co. LLPas of 31 Dec 2022 | 17.03m | 4.50% |
| BlackRock Fund Advisorsas of 31 Dec 2022 | 15.80m | 4.17% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Dec 2022 | 14.96m | 3.95% |
| SSgA Funds Management, Inc.as of 31 Dec 2022 | 14.12m | 3.73% |
| Capital Research & Management Co. (Global Investors)as of 31 Dec 2022 | 14.08m | 3.72% |
| Fundsmith LLPas of 31 Dec 2022 | 7.25m | 1.91% |
| Geode Capital Management LLCas of 31 Dec 2022 | 5.84m | 1.54% |
| Franklin Advisers, Inc.as of 31 Dec 2022 | 4.26m | 1.13% |
More ▼
Data from 31 Dec 2022 - 31 Dec 2022Source: FactSet Research Systems Inc.
